Friday 16 November 2018
Home      All news      Contact us     
cnbc.com - 29 days ago

Novartis raises 2018 sales outlook as Entresto, Cosentyx accelerate

Swiss drugmaker Novartis raised its full-year sales outlook and announced on Thursday the $2.1 billion acquisition of U.S. biopharmaceutical company Endocyte.

Related news

Latest News
Hashtags:   

Novartis

 | 

raises

 | 

sales

 | 

outlook

 | 

Entresto

 | 

Cosentyx

 | 

accelerate

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)

Sources